Theratechnologies Inc
TSX:TH
Theratechnologies Inc
Total Receivables
Theratechnologies Inc
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theratechnologies Inc
TSX:TH
|
Total Receivables
$10.5m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
43%
|
|
Zymeworks Inc
NYSE:ZYME
|
Total Receivables
$19.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
118%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Receivables
$15.3m
|
CAGR 3-Years
35%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Receivables
$5.5m
|
CAGR 3-Years
90%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Receivables
$28.9m
|
CAGR 3-Years
189%
|
CAGR 5-Years
135%
|
CAGR 10-Years
76%
|
|
Spectral Medical Inc
TSX:EDT
|
Total Receivables
CA$482k
|
CAGR 3-Years
-13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-3%
|
See Also
What is Theratechnologies Inc's Total Receivables?
Total Receivables
10.5m
USD
Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Total Receivables amounts to 10.5m USD.
What is Theratechnologies Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
43%
Over the last year, the Total Receivables growth was 1%. The average annual Total Receivables growth rates for Theratechnologies Inc have been -2% over the past three years , 6% over the past five years , and 43% over the past ten years .